BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32053465)

  • 1. Mystical and Other Alterations in Sense of Self: An Expanded Framework for Studying Nonordinary Experiences.
    Taves A
    Perspect Psychol Sci; 2020 May; 15(3):669-690. PubMed ID: 32053465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of consciousness and mystical-type experiences after acute LSD in humans.
    Liechti ME; Dolder PC; Schmid Y
    Psychopharmacology (Berl); 2017 May; 234(9-10):1499-1510. PubMed ID: 27714429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates.
    Barrett FS; Griffiths RR
    Curr Top Behav Neurosci; 2018; 36():393-430. PubMed ID: 28401522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel ego dissolution scale: A construct validation study.
    Sleight FG; Lynn SJ; Mattson RE; McDonald CW
    Conscious Cogn; 2023 Mar; 109():103474. PubMed ID: 36764162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naturalistic use of psychedelics is related to emotional reactivity and self-consciousness: The mediating role of ego-dissolution and mystical experiences.
    Orłowski P; Ruban A; Szczypiński J; Hobot J; Bielecki M; Bola M
    J Psychopharmacol; 2022 Aug; 36(8):987-1000. PubMed ID: 35475373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clarifying and measuring the characteristics of experiences that involve a loss of self or a dissolution of its boundaries.
    Canby NK; Lindahl J; Britton WB; Córdova JV
    Conscious Cogn; 2024 Mar; 119():103655. PubMed ID: 38346364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-response relationships of psilocybin-induced subjective experiences in humans.
    Hirschfeld T; Schmidt TT
    J Psychopharmacol; 2021 Apr; 35(4):384-397. PubMed ID: 33663259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors.
    Griffiths RR; Johnson MW; Richards WA; Richards BD; Jesse R; MacLean KA; Barrett FS; Cosimano MP; Klinedinst MA
    J Psychopharmacol; 2018 Jan; 32(1):49-69. PubMed ID: 29020861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meditation has stronger relationships with mindfulness, kundalini, and mystical experiences than yoga or prayer.
    de Castro JM
    Conscious Cogn; 2015 Sep; 35():115-27. PubMed ID: 26002763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mystical-type experiences occasioned by ketamine mediate its impact on at-risk drinking: Results from a randomized, controlled trial.
    Rothberg RL; Azhari N; Haug NA; Dakwar E
    J Psychopharmacol; 2021 Feb; 35(2):150-158. PubMed ID: 33307947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.
    Johnson MW; Hendricks PS; Barrett FS; Griffiths RR
    Pharmacol Ther; 2019 May; 197():83-102. PubMed ID: 30521880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do entheogen-induced mystical experiences boost the immune system? Psychedelics, peak experiences, and wellness.
    Roberts TB
    Adv Mind Body Med; 1999; 15(2):139-47. PubMed ID: 10367499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Illicit use of LSD or psilocybin, but not MDMA or nonpsychedelic drugs, is associated with mystical experiences in a dose-dependent manner.
    Lyvers M; Meester M
    J Psychoactive Drugs; 2012; 44(5):410-7. PubMed ID: 23457892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ego-Dissolution and Psychedelics: Validation of the Ego-Dissolution Inventory (EDI).
    Nour MM; Evans L; Nutt D; Carhart-Harris RL
    Front Hum Neurosci; 2016; 10():269. PubMed ID: 27378878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute Subjective Effects of Psychedelics within and Beyond WEIRD Contexts.
    Graziosi M; Singh M; Nayak SM; Yaden DB
    J Psychoactive Drugs; 2023; 55(5):558-569. PubMed ID: 37679890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mysticism and schizophrenia: A phenomenological exploration of the structure of consciousness in the schizophrenia spectrum disorders.
    Parnas J; Henriksen MG
    Conscious Cogn; 2016 Jul; 43():75-88. PubMed ID: 27258928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding the scope of "trans-humanism": situating within the framework of life and death education - the importance of a "trans-mystical mindset".
    Phan HP; Ngu BH; Hsu CS; Chen SC; Wu L
    Front Psychol; 2024; 15():1380665. PubMed ID: 38721316
    [No Abstract]   [Full Text] [Related]  

  • 18. The language of altered states.
    Oxman TE; Rosenberg SD; Schnurr PP; Tucker GJ; Gala G
    J Nerv Ment Dis; 1988 Jul; 176(7):401-8. PubMed ID: 3411311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why revelations have occurred on mountains? Linking mystical experiences and cognitive neuroscience.
    Arzy S; Idel M; Landis T; Blanke O
    Med Hypotheses; 2005; 65(5):841-5. PubMed ID: 16054773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mystical experience in the context of health care.
    Witte AS; van der Wal DM; Steyn HC
    J Holist Nurs; 2008 Jun; 26(2):84-92. PubMed ID: 18539874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.